|
Jan 13
|
3 Unstoppable Stocks to Buy in 2024
|
|
Jan 12
|
Two Health Care Leaders Scale New Highs On Big Wins
|
|
Jan 12
|
A Weight-Loss Drug Changed My Life. Will It Solve My Problem?
|
|
Jan 12
|
No Evidence New Obesity Drugs Cause Suicidal Thoughts, FDA Says
|
|
Jan 12
|
FDA Finds No Link Between Obesity Drugs and Suicidal Thoughts
|
|
Jan 11
|
Weight-Loss Drugs Don’t Cause Suicidal Thoughts, FDA Says
|
|
Jan 11
|
Walgreens, Eli Lilly, Crypto CEOs and more: C-Suite Insights
|
|
Jan 11
|
40 Cities with the Lowest Life Expectancy in the US
|
|
Jan 11
|
UPDATE 1-Weight loss drug windfall attracts pharma companies
|
|
Jan 11
|
15 States With Highest Rates of Eating Disorders
|
|
Jan 11
|
Drugmakers plot way into obesity market with deals and development
|
|
Jan 11
|
Why Eli Lilly Stock Skyrocketed 59% in 2023
|
|
Jan 11
|
Henlius and Sermonix Announce Strategic Collaboration and Exclusive License Agreements for Novel Endocrine Therapy Lasofoxifene
|
|
Jan 8
|
Alphabet's Isomorphic Labs In Drug Discovery Deals With Eli Lilly, Novartis
|
|
Jan 8
|
UPDATE 2-Lilly CEO says weight-loss drug Zepbound weekly prescriptions hit 25,000 in December
|
|
Jan 8
|
Lilly CEO says weight-loss drug Zepbound weekly prescriptions hit 25,000 in December
|
|
Jan 8
|
Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024
|
|
Jan 8
|
Eli Lilly CEO: 'I think a bet on Lilly is to bet we can keep on inventing new things'
|
|
Jan 8
|
Eli Lilly CEO talks expanding innovation past obesity drugs
|
|
Jan 8
|
Dow Jones Futures Fall As Boeing Plunges On 737 Max Woes; Can Market Rally Hold Key Levels?
|